IRIS BioTechnologies Inc.

Iris BioTechnologies has been perfecting the 21st Century tools necessary to bring P4 medicine to the clinic. Iris's state-of-the-art Nano-biochips™ and BioWindows™ medical informatics system are capable of capturing and analyzing the many alterations in cancer pathways by capturing mRNA, microRNA, proteins or other biomarkers. Our patented products were developed to overcome the sensitivity, specificity, speed and cost limitations of present state-of-the-art microarray technology. The Iris products are designed to be FDA approved, enabling them to be used in any certified laboratory in the United States.

Trial Care International LLC

Trial Care International (TCI) is a full service Contract Research Organization (CRO) providing a range of services to the pharmaceutical and biotech industry through long term partnerships with our clients. Our people provide a seamless extension to your project team by demonstrating dedication to achieve your goals and objectives, in a time and cost-efficient manner. TCI specializes in the management of Phase I-IV clinical trials in a wide range of therapeutic areas. We have learned from over a decade of experience in this field that the key to successful execution of clinical programs is listening to client's needs, setting goals while defining lines of communication. TCI's core team consists of senior experts with many years experience directing successful programs leading to FDA approvals. We have extensive expertise pertaining to trials utilizing imaging modalities such as PET/CT, MRI, CT and Ultrasound. We offer global reach through select partners throughout Europe and Asia. As a result, you can be confident that you are serviced by a team with the geographical locale, and clinical and regulatory expertise needed to achieve truly excellent results.

Research Strategies of Memphis

RESEARCH STRATEGIES OF MEMPHIS, LLC is an independent research site working towards a goal of better understanding psychiatric disorders by helping bring additional pharmaceutical products to market for both patients and professionals. RSM began in 2005 as a collaboration of renowned research industry professionals. Our Physician Investigators and Chief Executive Officer, Becky Pace, RN, have over fifty years combined experinence in clinical resarch. Research Strategies investigators are board-certified or board-eligible physicians with a dedication to quality and patient care. RESEARCH STRATEGIES OF MEMPHIS, LLC (RSM) provides professional care, health examinations, study medications and close monitoring at no cost to you or your family and NO insurance is necessary. Seeking participants of all ages for our research studies of: Depression - Anxiety - Schizophrenia or Schizoaffective Disorder Bipolar Disorder - Attention Deficit hyperactivity Disorder TO FIND OUT HOW YOU MAY QUALIFY IN ANY OF THE ONGOING STUDIES, CALL OUR OFFICE TODAY! Today's Research . . . Tomorrow's Cure

RESCUESKIN Laboratories

The most advanced skincare product on the market today we are the only skincare science company that developed our core actives from Adult Human Stem Cells from bone marrow—recognized in the scientific community as the golden standard source for stem cells. We culture these stem cells, which are then filtered to collect active cellular components such as peptides, proteins, enzymes, cytokines, and exosomes that are all present when healthy skin cells grow. Our core formula contains these exclusive cellular actives. Every step, from the sourcing of the original cells to final formula production, is done at our research facility in Aliso Viejo, California. A truly American made product from beginning to the end. (Ok, maybe only some of our packaging are made in China but that's it.)

DiscoveryBioMed, Inc.

DiscoveryBioMed, Inc. (DBM) is a life sciences and biotechnology company focused on integrating biologically- and disease-relevant human cell cultures and lines into all relevant steps in the Drug Discovery Critical Path. DBM specializes in multiplexed bioassays of targets and phenotypes using both mono- and multi-culture designs for primary Drug Discovery, as well as, hit-to-lead validation of existing hit-to-lead assets. Complementing its Drug Discovery efforts, DBM also specializes in custom cell culture and engineering and implementation of such cells at any and all inflections points within the Critical Path. It is DBM's belief that our approach to Drug Discovery and Development serves as a complement to the more traditional approach within the BioPharmaceutical Indstury to improve the viability of hit, validated hit-to-lead and lead clinical candidate drugs.